Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.
about
Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration.Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.Modification of enrofloxacin treatment regimens for poultry experimentally infected with Salmonella enterica serovar Typhimurium DT104 to minimize selection of resistance.Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.Efficacy of fluoroquinolones against Leptospira interrogans in a hamster modelInfluence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.Protein binding: do we ever learn?Besifloxacin ophthalmic suspension: emerging evidence of its therapeutic value in bacterial conjunctivitis.Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria.Relationship between pharmacodynamic indices and killing patterns in vitro.Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery.
P2860
Q33819854-C27A5841-AB4E-4290-8145-8F2428F088EFQ34301541-F171DEDA-63DA-4B9B-81FA-BAE501D20E89Q34368520-2DD0B2AE-4118-4300-813B-2B689B28EE07Q35105913-87D9EA9C-F22F-4296-BE68-94A1D2358D80Q35215450-C4067E10-FCC7-4789-AB65-EF9930B0D870Q35636012-B9E2A00B-C050-46AB-A2AB-25537FCA567DQ35878989-7EADC186-00A0-4D79-85A8-1DD2B03E351CQ36505518-A36603F1-4DFD-479B-9361-456767AA7A0FQ36969966-C0777A17-ACAF-442C-9941-A3FFEA7975DEQ37115679-E06CCDC3-2C5B-4F54-8368-0B6B52BE790CQ37115690-D5211717-DF80-4D32-B3E4-356FADBDE14BQ37563029-01570E32-C256-4DCC-8963-470ECBE945E8Q37867260-412AD5F9-7641-4524-A6AF-204FA047D418Q37871252-E2CF3CEB-B569-4A89-AF4F-02C71404D1EBQ38122147-CD8C1F59-32F7-40F2-9990-586DED8E6CF8Q39293585-AF3A15CD-5147-4FAD-B472-7285F8FC8368Q39735382-69E42B85-6F86-4820-8C16-2FF07F8FC1E8Q43207762-B2EBF619-3359-4DCE-9154-CCEED4CA2E53Q43949659-C9A6249D-6A71-4A5F-8582-8F244530E5CA
P2860
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@ast
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@en
type
label
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@ast
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@en
prefLabel
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@ast
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@en
P2093
P2860
P1476
Pharmacodynamics of levofloxac ...... ea under the curve/MIC ratios.
@en
P2093
F Fraschini
F Scaglione
J W Mouton
P2860
P304
P356
10.1128/AAC.47.9.2749-2755.2003
P407
P577
2003-09-01T00:00:00Z